Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome

Hsin Ching Lin, Michael Friedman, Hsueh Wen Chang, Mao Chang Su, Meghan N. Wilson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 (p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0-10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p <0.0001, paired t test).

Original languageEnglish (US)
Pages (from-to)1070-1076
Number of pages7
JournalActa Oto-Laryngologica
Volume130
Issue number9
DOIs
StatePublished - Sep 1 2010

Fingerprint

Obstructive Sleep Apnea
Tongue
Morbidity
Velopharyngeal Insufficiency
Snoring
Apnea
Therapeutics
Visual Analog Scale
Oxygen
Safety

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Lin, Hsin Ching ; Friedman, Michael ; Chang, Hsueh Wen ; Su, Mao Chang ; Wilson, Meghan N. / Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome. In: Acta Oto-Laryngologica. 2010 ; Vol. 130, No. 9. pp. 1070-1076.
@article{60ca21e9932d4a9eb9547665408f62de,
title = "Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome",
abstract = "Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5{\%} (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 (p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation ({\%}), and bed partner assessed snoring visual analog scale (0-10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p <0.0001, paired t test).",
author = "Lin, {Hsin Ching} and Michael Friedman and Chang, {Hsueh Wen} and Su, {Mao Chang} and Wilson, {Meghan N.}",
year = "2010",
month = "9",
day = "1",
doi = "10.3109/00016481003606240",
language = "English (US)",
volume = "130",
pages = "1070--1076",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "9",

}

Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome. / Lin, Hsin Ching; Friedman, Michael; Chang, Hsueh Wen; Su, Mao Chang; Wilson, Meghan N.

In: Acta Oto-Laryngologica, Vol. 130, No. 9, 01.09.2010, p. 1070-1076.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome

AU - Lin, Hsin Ching

AU - Friedman, Michael

AU - Chang, Hsueh Wen

AU - Su, Mao Chang

AU - Wilson, Meghan N.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 (p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0-10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p <0.0001, paired t test).

AB - Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 (p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0-10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p <0.0001, paired t test).

UR - http://www.scopus.com/inward/record.url?scp=77956049812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956049812&partnerID=8YFLogxK

U2 - 10.3109/00016481003606240

DO - 10.3109/00016481003606240

M3 - Article

C2 - 20218946

AN - SCOPUS:77956049812

VL - 130

SP - 1070

EP - 1076

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 9

ER -